Digital imaging company Canon USA, Melville, NY, announced on March 2 the establishment of Canon BioMedical Inc, a new wholly owned subsidiary that will serve as a worldwide headquarters for its biomedical business. The new company will conduct development, manufacturing, and marketing operations relating to Canon’s life science and molecular diagnostics platform, and seek to expand the use of Canon technology into other medical fields.

Based in Melville, Canon BioMedical will be led Akiko Tanaka, president and CEO. According to a company press release, it will “look for long-term future growth opportunities in previously untapped markets for Canon such as life science, healthcare, and medical analysis through the use of existing and emerging Canon technology, as well as strategic partnerships. “

Commenting on the launch of the new company, Joe Adachi, Canon chairman and CEO, said, “We look forward to bringing Canon technology to clinicians and scientists all over the world in an effort to assist in improving human health and in advancing science.”